Wood R - Search Results

1

Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial.

Sanne I, Orrell C, Fox MP, Conradie F, Ive P, Zeinecker J, Cornell M, Heiberg C, Ingram C, Panchia R, Rassool M, Gonin R, Stevens W, Truter H, Dehlinger M, van der Horst C, McIntyre J, Wood R; CIPRA-SA Study Team. Sanne I, et al. Among authors: wood r. Lancet. 2010 Jul 3;376(9734):33-40. doi: 10.1016/S0140-6736(10)60894-X. Lancet. 2010. PMID: 20557927 Free PMC article. Clinical Trial.

2

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.

Badri M, Wilson D, Wood R. Badri M, et al. Among authors: wood r. Lancet. 2002 Jun 15;359(9323):2059-64. doi: 10.1016/S0140-6736(02)08904-3. Lancet. 2002. PMID: 12086758

3

Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings.

Badri M, Wood R. Badri M, et al. Among authors: wood r. AIDS. 2003 Mar 7;17(4):541-5. doi: 10.1097/00002030-200303070-00009. AIDS. 2003. PMID: 12598774

4

Adherence is not a barrier to successful antiretroviral therapy in South Africa.

Orrell C, Bangsberg DR, Badri M, Wood R. Orrell C, et al. Among authors: wood r. AIDS. 2003 Jun 13;17(9):1369-75. doi: 10.1097/00002030-200306130-00011. AIDS. 2003. PMID: 12799558 Clinical Trial.

5

Antiretroviral therapy in a community clinic--early lessons from a pilot project.

Bekker LG, Orrell C, Reader L, Matoti K, Cohen K, Martell R, Abdullah F, Wood R. Bekker LG, et al. Among authors: wood r. S Afr Med J. 2003 Jun;93(6):458-62. S Afr Med J. 2003. PMID: 12916388

6

Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines.

Badri M, Bekker LG, Orrell C, Pitt J, Cilliers F, Wood R. Badri M, et al. Among authors: wood r. AIDS. 2004 May 21;18(8):1159-68. doi: 10.1097/00002030-200405210-00009. AIDS. 2004. PMID: 15166531

7

Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme.

Lawn SD, Bekker LG, Myer L, Orrell C, Wood R. Lawn SD, et al. Among authors: wood r. AIDS. 2005 Nov 18;19(17):2050-2. doi: 10.1097/01.aids.0000191232.16111.f9. AIDS. 2005. PMID: 16260920 No abstract available.

8

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.

Lawn SD, Badri M, Wood R. Lawn SD, et al. Among authors: wood r. AIDS. 2005 Dec 2;19(18):2109-16. doi: 10.1097/01.aids.0000194808.20035.c1. AIDS. 2005. PMID: 16284460

9

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.

Lawn SD, Myer L, Orrell C, Bekker LG, Wood R. Lawn SD, et al. Among authors: wood r. AIDS. 2005 Dec 2;19(18):2141-8. doi: 10.1097/01.aids.0000194802.89540.e1. AIDS. 2005. PMID: 16284464

10

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R. Badri M, et al. Among authors: wood r. Antivir Ther. 2006;11(1):63-72. Antivir Ther. 2006. PMID: 16518961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,487 results

Search Page

Filters